Sustained action formulation of cyclosporin form 2
AssigneeAllergan, Inc.
InventorsWendy M. Blanda, Mayssa Attar
Life of this patent
Estimating the term…
Abstract
Disclosed herein are methods of treating diseases of the eye by administering to the subconjunctival space a formulation comprising cyclosporin A form 2 and a hydrogel.
Claims2
A method of treating a condition selected from the group consisting of dry eye, blepharitis, meibomian gland disease, impaired corneal sensitivity, allergic conjunctivitis, atopic keratoconjunctivitis, vernal keratoconjunctivitis, and ptyregia, the method comprising the step of administering to a subconjunctival space of an eye of a patient having the condition a formulation comprising cyclosporin A form 2 and a hydrogel, the hydrogel selected from the group consisting of hyaluronic acid, hydroxypropyl cellulose, hydroxypropylmethyl cellulose, hydroxyethylcellulose, polyvinyl pyrolidone, carboxymethylcellulose hydroxyethyl cellulose, and polyvinylpyrrolidone.
Dependencies are inferred from the claim text.